Putnam BioRevolution ETF Rating → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free SYNB Stock Alerts $30.48 +0.16 (+0.53%) (As of 05/9/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Putnam BioRevolution ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy2.73Holdings in SYNB have an aggregate rating of Moderate Buy based on 458 analyst ratings issued in the past year covering 31 companies (89.7% of the portfolio).SYNB Aggregate Price Target$36.1418.55% UpsideHigh Prediction$43.38Average Prediction$36.14Low Prediction$27.26Holdings in SYNB have an aggregate price target of $36.14 and a range of $27.26 to $43.38 covering 31 companies (89.7% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 SYNB Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.66%NVDANVIDIA$887.47-1.8%4 of 5 stars2.95$944.05 6.4%42Analyst Forecast7.30%TMOThermo Fisher Scientific$577.93+0.7%5 of 5 stars2.71$607.35 5.1%176.69%DHRDanaher$251.48+0.8%5 of 5 stars2.64$267.31 6.3%14Dividend Announcement5.56%BIOBio-Rad Laboratories$277.31+3.4%5 of 5 stars2.80$461.00 66.2%5Earnings ReportAnalyst Forecast5.47%GOOGLAlphabet$169.96+0.3%4 of 5 stars2.89$190.60 12.1%364.60%CTVACorteva$57.83+1.8%4 of 5 stars2.73$63.24 9.4%22Insider Selling4.49%NVZMYNovozymes A/S$60.40+0.1%4 of 5 stars2.673Gap Down4.24%ABBVAbbVie$160.380.0%4 of 5 stars2.77$174.31 8.7%13Earnings Report3.93%ASNDAscendis Pharma A/S$133.13-0.6%1 of 5 stars2.88$173.88 30.6%83.57%LLYEli Lilly and Company$771.55-0.4%5 of 5 stars2.84$757.95 -1.8%19Earnings ReportDividend Announcement3.46%AVTRAvantor$24.78+2.1%5 of 5 stars2.75$26.71 7.8%16Positive News3.37%DDDuPont de Nemours$78.80+0.8%5 of 5 stars2.27$80.00 1.5%11Insider Selling3.16%REGNRegeneron Pharmaceuticals$968.00+1.3%4 of 5 stars2.70$981.71 1.4%202.88%ZTSZoetis$168.13+1.9%5 of 5 stars3.00$211.75 25.9%7Analyst Forecast2.62%AZNAstraZeneca$77.61+0.8%2 of 5 stars2.57$81.00 4.4%72.46%BIIBBiogen$222.75+1.4%5 of 5 stars2.65$290.92 30.6%262.19%NGVTIngevity$54.41+0.8%3 of 5 stars2.33$55.00 1.1%6Analyst Forecast2.15%LULULululemon Athletica$352.95+2.1%5 of 5 stars2.67$474.79 34.5%30Analyst Forecast2.04%EXASExact Sciences$54.15-9.0%4 of 5 stars2.92$99.07 82.9%13Analyst ForecastNews CoverageGap DownHigh Trading Volume1.92%PPGPPG Industries$134.35+1.2%5 of 5 stars2.47$155.47 15.7%17Insider Buying1.51%BGBunge Global$105.39+0.0%4 of 5 stars2.70$121.00 14.8%10Dividend IncreasePositive News1.44%TWSTTwist Bioscience$43.20+4.3%2 of 5 stars3.00$42.50 -1.6%6Insider Selling1.33%DARDarling Ingredients$45.98+3.8%5 of 5 stars2.80$72.55 57.8%10Positive News1.29%VRTXVertex Pharmaceuticals$418.99+0.0%4 of 5 stars2.48$432.18 3.1%25Earnings ReportAnalyst Forecast1.04%RCKTRocket Pharmaceuticals$23.33+1.5%5 of 5 stars2.89$52.13 123.4%9Earnings ReportAnalyst ForecastAnalyst Revision0.94%TECHBio-Techne$79.63+3.3%4 of 5 stars2.82$80.50 1.1%110.59%CRSPCRISPR Therapeutics$53.55+0.5%3 of 5 stars2.38$77.23 44.2%17Earnings ReportUpcoming EarningsAnalyst ForecastNews Coverage0.56%DNAGinkgo Bioworks$0.92+2.2%2 of 5 stars2.00$2.20 139.8%5Gap UpHigh Trading Volume0.44%ALNYAlnylam Pharmaceuticals$151.37-0.6%5 of 5 stars2.59$216.19 42.8%17Analyst Forecast0.40%TXG10x Genomics$26.39+4.1%5 of 5 stars2.58$48.50 83.8%120.40%LNZALanzaTech Global$2.45-8.6%2 of 5 stars2.75$6.33 158.5%4Analyst ForecastNews CoverageGap DownHigh Trading Volume This page (NYSEARCA:SYNB) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
